Heart Failure POC and LOC Devices Market to Surge from USD 127.79 Million in 2024 to USD 451.93 Million by 2033 - DataM Intelligence

Market Size and Growth:

Heart Failure POC and LOC Devices Market Size reached US$ 127.79 Million in 2024 from US$ 112.17 Million in 2023 and is expected to reach US$ 451.93 Million by 2033, growing at a CAGR of 15.2% during the forecast period 2025-2033.

The Heart Failure POC and LOC Devices Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Heart Failure POC and LOC Devices market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/heart-failure-poc-and-loc-devices-market?sz

The Heart Failure Point-of-Care (POC) and Lab-on-Chip (LOC) Devices Market refers to diagnostic technologies designed for rapid, accurate, and decentralized detection and monitoring of heart failure. These devices enable real-time testing at patient care sites or through miniaturized lab-on-chip platforms, improving early diagnosis, treatment decisions, patient outcomes, and reducing the burden on traditional laboratory systems.

Key Developments of USA and Japan:

USA (June - September 2025):

POC Device: An AI-powered system developed by Simplex Quantum, in collaboration with the University of Tokyo Hospital, was published in a clinical study showing it can accurately assess heart failure severity and track disease progression using a single-lead ECG from common devices like the Apple Watch. The AI model, with a 91.6% accuracy rate, has the potential to provide on-demand, at-home monitoring to reduce hospitalizations. (April 24, 2025)

LOC Device: Research published in the journal Lab on a Chip detailed a new microfluidic "artery-on-a-chip" model that mimics human artery disease processes in vitro. This high-throughput platform can be used for more accurate drug screening and therapeutic development for cardiovascular diseases. (June 2025)

Japan (June - September 2025):

POC Device: Updated 2025 guidelines from the Japanese Heart Rhythm Society encourage the clinical use of wearable ECG devices. This development, combined with the relaxation of direct-to-consumer advertising rules, is boosting the retail sale and adoption of AI-enhanced, cloud-linked wearable monitors for remote cardiac monitoring. (March 14, 2025)

LOC Device: MicroPort CRM announced the first implantation in Japan as part of its international post-market clinical study, PIANO. The study is assessing the safety and performance of its cardiac resynchronization therapy defibrillators (CRT-D) with proprietary SonR® technology, which uses a hemodynamic sensor to automatically optimize a patient's heart function. (May 19, 2025)

Key Players:

Abbott
F. Hoffmann-La Roche Ltd
Siemens Healthineers
QuidelOrtho Corporation
Jant Pharmacal Corporation
Trinity Biotech
bioMérieux
Beckman Coulter, Inc.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=heart-failure-poc-and-loc-devices-market

Market Segmentation:

By Test Type: Proteomic Testing, Metabolomic Testing, Genomic Testing.

By Technology: Microfluidics, Array-based Systems, Others.

By Product Type: Wearable Devices, Implantable Devices, Handheld Devices.

By End User: Hospitals, Specialty Clinics, Homecare Settings, Assisted Living Healthcare Facilities, Laboratories, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/heart-failure-poc-and-loc-devices-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Heart Failure POC and LOC Devices market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Heart Failure POC and LOC Devices Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Heart Failure POC and LOC Devices market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Heart Failure POC and LOC Devices Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Heart Failure POC and LOC Devices Market in 2025?
◆ What is the projected growth rate of the Heart Failure POC and LOC Devices Market through 2033?
◆ Who are the key players in the Heart Failure POC and LOC Devices Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.